Bitter-sweet? The role of glycemic control in breast reduction surgery.
Abstract
[BACKGROUND] The American Society of Plastic Surgeons guidelines emphasize the need for additional evidence regarding perioperative glycemic control in patients with diabetes undergoing breast reduction surgery. This study evaluates the association between preoperative hemoglobin A1c (HbA) levels and postoperative complications in patients with diabetes undergoing reduction mammaplasty.
[METHODS] A retrospective cohort study of the National Surgical Quality Improvement Program (NSQIP) database was performed, identifying patients diagnosed with diabetes who underwent breast reduction surgery from 2021 to 2023. Patients were stratified by preoperative HbA levels: well-controlled (HbA < 6.5%) versus poorly controlled (HbA ≥ 6.5%). Demographics, surgical characteristics, and 30-day postoperative outcomes were compared between groups. Multivariable logistic regression analysis was performed to identify independent risk factors for complications.
[RESULTS] A total of 364 female patients with diabetes met the inclusion criteria, of whom 293 (80%) had non–insulin-dependent and 71 (20%) had insulin-dependent diabetes. Based on HbA levels, 206 patients (57%) had well-controlled diabetes, and 158 (43%) had poorly controlled diabetes. The groups were comparable in age, BMI, and surgical characteristics. The overall complication rate was 10.7% ( = 39), with superficial surgical site infections being the most common ( = 22, 6.0%). Patients with poorly controlled diabetes had higher rates complications overall (13.0% vs. 9.2%, = 0.29) and readmission (4.4% vs. 1.0%, = 0.044). In multivariable analysis, HbA ≥ 6.5% was independently associated with an increased risk of complications (OR 2.2, 95% CI 1.0–4.7, = 0.047).
[CONCLUSION] Patients with diabetes and poorly controlled glycemic status demonstrate a higher likelihood of postoperative complications following breast reduction surgery, although the association reached only borderline statistical significance. These findings support the clinical plausibility that suboptimal glycemic control may contribute to increased perioperative risk and may help inform patient counseling and surgical decision-making in this population. Further research is needed to clarify the extent to which preoperative glycemic optimization influences outcomes in this population.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12893-026-03507-w.
[METHODS] A retrospective cohort study of the National Surgical Quality Improvement Program (NSQIP) database was performed, identifying patients diagnosed with diabetes who underwent breast reduction surgery from 2021 to 2023. Patients were stratified by preoperative HbA levels: well-controlled (HbA < 6.5%) versus poorly controlled (HbA ≥ 6.5%). Demographics, surgical characteristics, and 30-day postoperative outcomes were compared between groups. Multivariable logistic regression analysis was performed to identify independent risk factors for complications.
[RESULTS] A total of 364 female patients with diabetes met the inclusion criteria, of whom 293 (80%) had non–insulin-dependent and 71 (20%) had insulin-dependent diabetes. Based on HbA levels, 206 patients (57%) had well-controlled diabetes, and 158 (43%) had poorly controlled diabetes. The groups were comparable in age, BMI, and surgical characteristics. The overall complication rate was 10.7% ( = 39), with superficial surgical site infections being the most common ( = 22, 6.0%). Patients with poorly controlled diabetes had higher rates complications overall (13.0% vs. 9.2%, = 0.29) and readmission (4.4% vs. 1.0%, = 0.044). In multivariable analysis, HbA ≥ 6.5% was independently associated with an increased risk of complications (OR 2.2, 95% CI 1.0–4.7, = 0.047).
[CONCLUSION] Patients with diabetes and poorly controlled glycemic status demonstrate a higher likelihood of postoperative complications following breast reduction surgery, although the association reached only borderline statistical significance. These findings support the clinical plausibility that suboptimal glycemic control may contribute to increased perioperative risk and may help inform patient counseling and surgical decision-making in this population. Further research is needed to clarify the extent to which preoperative glycemic optimization influences outcomes in this population.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12893-026-03507-w.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | breast reduction
|
유방성형술 | dict | 4 | |
| 해부 | breast
|
유방 | dict | 4 | |
| 시술 | mammaplasty
|
유방성형술 | dict | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | HbA
→ hemoglobin A1c
|
scispacy | 1 | ||
| 약물 | [RESULTS] A
|
scispacy | 1 | ||
| 약물 | 10.1186/s12893
|
scispacy | 1 | ||
| 질환 | diabetes
|
C0011847
Diabetes
|
scispacy | 1 | |
| 질환 | insulin-dependent diabetes
|
C0011854
Diabetes Mellitus, Insulin-Dependent
|
scispacy | 1 | |
| 질환 | infections
|
C0851162
Infections of musculoskeletal system
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | hemoglobin
|
scispacy | 1 | ||
| 기타 | insulin-dependent
|
scispacy | 1 | ||
| 기타 | HbA
→ hemoglobin A1c
|
scispacy | 1 | ||
| 기타 | CI 1.0–4.7
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | SUPPLEMENTARY
|
scispacy | 1 |
📑 인용 관계
이 논문이 참조한 문헌 38
- Sugar-Coated Complications? The Impact of Diabetes on Outcomes of Breast Reduction.
- Protein as a preoperative predictor - Impact of hypoalbuminemia on 30-day outcomes of breast reducti…
- Safety of Combined Versus Isolated Cosmetic Breast Surgery and Abdominoplasty: Insights from a Multi…
- The Impact of Body Mass Index on Breast Reduction Outcomes: A Multi-Institutional Data Analysis of 4…
- Investigating the Impact of Operative Time on Breast Augmentation Outcomes.
- Postoperative Outcomes After Breast Reduction: Do Racial Disparities Exist?
- Reduction mammaplasty relieves depression in women with macromastia: A systematic review.
- Patient-Reported Outcomes After Reduction Mammoplasty Using BREAST-Q: A Systematic Review and Meta-A…
- American Society of Plastic Surgeons Evidence-Based Clinical Practice Guideline Revision: Reduction …
- Discussion of preoperative mammography in women undergoing reduction mammaplasty.
- Evaluation of Diabetes Mellitus as a Risk Factor for Major Complications in Patients Undergoing Aest…
- Complications following reduction mammaplasty: a review of 3538 cases from the 2005-2010 NSQIP data …
- A multi-institutional perspective of complication rates for elective nonreconstructive breast surger…
외부 PMID 25건 (DB 미수집)
- PMID 24368606 ↗
- PMID 24903577 ↗
- PMID 25069580 ↗
- PMID 26503187 ↗
- PMID 27398023 ↗
- PMID 28894673 ↗
- PMID 29581095 ↗
- PMID 29891083 ↗
- PMID 32190696 ↗
- PMID 32244718 ↗
- PMID 32907422 ↗
- PMID 33306559 ↗
- PMID 33847752 ↗
- PMID 34526862 ↗
- PMID 34619855 ↗
- PMID 34949439 ↗
- PMID 35721703 ↗
- PMID 35887276 ↗
- PMID 37061429 ↗
- PMID 37788019 ↗
- PMID 37863683 ↗
- PMID 38078589 ↗
- PMID 39874559 ↗
- PMID 40319006 ↗
- PMID 40377794 ↗
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.